Synribo

(omacetaxine mepesuccinate)
Synribo 3.5 MG Injection
NO BLACK BOX WARNING

Dosage & administration

biomarker testing

Synribo clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Synribo prescribing information

prior authorization

Synribo prior authorization resources

Learn More

Benefits investigation

PDF
SynCare Prescription & Service Request Form
Learn More

financial assistance

Synribo financial assistance options

Co-pay savings program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

PDF
TevaCares Patient Assistance Program Application
Learn More

patient education

Synribo patient education

Getting started on Synribo

BRAND PAGE
Instructions For Use: Chronic or Accelerated Phase Chronic Myeloid Leukemia (CML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Learn More

Other resources

Learn More

people also ask

Synribo FAQs

How is the dosage of Synribo?Synribo is available in 1 dosages, including 3.5 mg Injection
What does Synribo treat?Synribo treats
How Is Synribo Administered?Synribo is administered as a Injectable
FAQ Data Source